~~<i id='8E12D80F24'><strike id='8E12D80F24'><tt id='8E12D80F24'><pre id='8E12D80F24'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：fashion 2025-08-28 08:41:03 - browse：6121

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Ozempic has benefits for kidney disease as well as diabetes

focus

hotspot

Wikipedia

entertainment

Wikipedia

leisure time

BloombergAlandmarkstudythatfoundtheblockbusterobesitydrugWegovyreducesthechanceofheartproblemsaddsur

WSS

The best solution to the drug shortages problem

Harvard's David Sinclair gets blowback over aging

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

South Korea throws huge K

Medicare drug price negotiation continues, as pharma counteroffers

What to know about Virgin Galactic's 1st mission taking paying customers to space

focus

leisure time

focus

What does generative AI mean for health care? We asked experts

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Malaria cases in Florida and Texas: Here’s what you need to know

South Korea throws huge K

Guidelines to prevent youth baseball injuries need more muscle

Drastic changes should bring profitability, startup health insurers say

Medical records are filled with copy

NIH trials fail to test meaningful long Covid therapies, experts say

Wildfire smoke exposes gaps in outdoor worker protections

Wegovy’s successful heart trial raises vital question about weight loss

hotspot

Methadone doses haven’t kept up in the age of fentanyl

Microsoft's Peter Lee: Generative AI could help doctors be more human

Readout Newsletter: BridgeBio, Akero, and human embryo models

Methadone doses haven’t kept up in the age of fentanyl

For AI in health care standards, federal regulators join with industry group

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Wikipedia

entertainment

Wikipedia

leisure time